TELO
Telomir Pharmaceuticals, Inc.
0.5950
+0.02 (+2.73%)
52w low 0.5450
1.58 high
4.8% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| Return on Equity | -- | -1,053.5% | -15.8% | -34.9% | -20.0% | -34.2% | |
| Return on Assets | -- | -611.1% | -14.9% | -28.1% | -17.1% | -32.1% | |
| Return on Inv Capital | -- | -832.1% | -12.5% | -27.6% | -15.8% | -27.0% | |
| Liquidity | |||||||
| Current Ratio | -- | 2.38x | 17.51x | 5.14x | 7.00x | 16.14x | |
| Quick Ratio | -- | 2.38x | 17.51x | 5.14x | 7.00x | 16.14x | |
| Cash Ratio | -- | 2.17x | 17.33x | 5.10x | 6.72x | 15.55x | |
| Leverage | |||||||
| Interest Coverage | -- | -3776.86x | -- | -1486.01x | -788.60x | -567.54x | |
| Equity Multiplier | -- | 1.72x | 1.06x | 1.24x | 1.17x | 1.07x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | -- | 0.14x | 0.84x | 0.58x | 1.79x | 0.59x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--